Acetylcholinesterase

acetylcholinesterase
Identifiers
EC number 3.1.1.7
CAS number 9000-81-1
Databases
IntEnz IntEnz view
BRENDA BRENDA entry
ExPASy NiceZyme view
KEGG KEGG entry
MetaCyc metabolic pathway
PRIAM profile
PDB structures RCSB PDB PDBe PDBsum
Gene Ontology AmiGO / EGO
Acetylcholinesterase

PDB rendering based on 1b41.
.
Identifiers
Symbols ACHE; ARACHE; N-ACHE; YT
External IDs OMIM100740 MGI87876 HomoloGene543 GeneCards: ACHE Gene
EC number 3.1.1.7
RNA expression pattern
More reference expression data
Orthologs
Species Human Mouse
Entrez 43 11423
Ensembl ENSG00000087085 ENSMUSG00000023328
UniProt P22303 Q543Z1
RefSeq (mRNA) NM_000665.3 NM_009599.3
RefSeq (protein) NP_000656.1 NP_033729.1
Location (UCSC) Chr 7:
100.49 – 100.49 Mb
Chr 5:
137.73 – 137.74 Mb
PubMed search [1] [2]

Acetylcholinesterase, also known as AChE or acetylcholine acetylhydrolase, is an enzyme that degrades (through its hydrolytic activity) the neurotransmitter acetylcholine, producing choline and an acetate group. It is mainly found at neuromuscular junctions and cholinergic nervous system, where its activity serves to terminate synaptic transmission. AChE has a very high catalytic activity — each molecule of AChE degrades about 25000 molecules of acetylcholine per second. The choline produced by the action of AChE is recycled — it is transported, through reuptake, back into nerve terminals where it is used to synthesize new acetylcholine molecules.[1]

Acetylcholinesterase is also found on the red blood cell membranes, where it constitutes the Yt blood group antigen. Acetylcholinesterase exists in multiple molecular forms, which possess similar catalytic properties, but differ in their oligomeric assembly and mode of attachment to the cell surface.

In humans acetylcholinesterase is encoded by the ACHE gene.[2]

Contents

Species distribution

Acetylcholine is widely expressed in eukaryotes including at least some plants.[3]

AChE gene

In mammals, acetylcholinesterase is encoded by a single AChE gene while some invertebrates have multiple acetylcholinesterase genes. Diversity in the transcribed products from the sole mammalian gene arises from alternative mRNA splicing and post-translational associations of catalytic and structural subunits. There are three known forms: T (tail), R (read through), and H(hydrophobic).[4]

AChET

The major form of acetylcholinesterase found in brain, muscle, and other tissues, known as is the hydrophilic species, which forms disulfide-linked oligomers with collagenous, or lipid-containing structural subunits. In the neuromuscular junctions AChE expresses in asymmetric form which associates with ColQ or subunit. In the central nervous system it is associated with PRiMA which stands for Proline Rich Membrane anchor to form symmetric form. In either case, the ColQ or PRiMA anchor serves to maintain the enzyme in the intercellular junction, ColQ for the neuromuscular junction and PRiMA for synapses.

AChEH

The other, alternatively-spliced form expressed primarily in the erythroid tissues, differs at the C-terminus, and contains a cleavable hydrophobic peptide with a PI-anchor site. It associates with membranes through the phosphoinositide (PI) moieties added post-translationally.[5]

AChER

The third type has, so far, only been found in Torpedo sp. and mice although it is hypothesized in other species. It is thought to be involved in the stress response and, possibly, inflammation.[6]

AChE inhibitors

Acetylcholinesterase is the target of many Alzheimer's Dementia drugs and sage oil, nerve gases(particularly the organophosphates (e.g. Sarin) and insecticides (e.g. carbaryl)). These agents — known as cholinesterase inhibitors — block the function of acetylcholinesterase and thus cause more acetylcholine to accumulate in the synaptic cleft.

Excess acetylcholine causes neuromuscular paralysis (i.e. interminable muscle contractions) throughout the entire body, leading to death by asphyxiation.[1]

Cholinesterase inhibitor may also be used in treatment of Lewy Body Dementia.

Cholinesterase inhibitors may be reversible inhibitors or quasi-irreversible inhibitors.

An endogenous inhibitor of AChE in neurons is Mir-132 microRNA, which may limit inflammation in the brain by silencing the expression of this protein and allowing ACh to act an in anti-inflammatory capacity.[7]

It has been shown that the main active ingredient in cannabis, tetrahydrocannibinol, is a competitive inhibitor of acetylcholinesterase.[8]

See also

References

  1. ^ a b Dale Purves, George J. Augustine, David Fitzpatrick, William C. Hall, Anthony-Samuel LaMantia, James O. McNamara, and Leonard E. White (2008). Neuroscience. 4th ed.. Sinauer Associates. pp. 121–2. ISBN 978-0-87893-697-7. 
  2. ^ Ehrlich G, Viegas-Pequignot E, Ginzberg D, Sindel L, Soreq H, Zakut H (August 1992). "Mapping the human acetylcholinesterase gene to chromosome 7q22 by fluorescent in situ hybridization coupled with selective PCR amplification from a somatic hybrid cell panel and chromosome-sorted DNA libraries". Genomics 13 (4): 1192–7. doi:10.1016/0888-7543(92)90037-S. PMID 1380483. 
  3. ^ Momonoki YS (May 1992). "Occurrence of Acetylcholine-Hydrolyzing Activity at the Stele-Cortex Interface". Plant Physiol. 99 (1): 130–133. doi:10.1104/pp.99.1.130. PMC 1080416. PMID 16668839. http://www.plantphysiol.org/cgi/pmidlookup?view=long&pmid=16668839. 
  4. ^ Massoulié J, Perrier N, Noureddine H, Liang D, Bon S (2008). "Old and new questions about cholinesterases.". Chem Biol Interact 175 (1-3): 30–44. doi:10.1016/j.cbi.2008.04.039. PMID 18541228. 
  5. ^ "Entrez Gene: ACHE acetylcholinesterase (Yt blood group)". http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=43. 
  6. ^ Dori A, Ifergane G, Saar-Levy T, Bersudsky M, Mor I, Soreq H, Wirguin I (2007). "Readthrough acetylcholinesterase in inflammation-associated neuropathies.". Life Sci 80 (24-25): 2369–74. doi:10.1016/j.lfs.2007.02.011. PMID 17379257. 
  7. ^ Shaked I, Meerson A, Wolf Y, Avni R, Greenberg D, Gilboa-Geffen A, Soreq H (2009). "MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase". Immunity 31 (6): 965–73. doi:10.1016/j.immuni.2009.09.019. PMID 20005135. 
  8. ^ Eubanks LM, Rogers CJ, Beuscher AE 4th, Koob GF, Olson AJ, Dickerson TJ, Janda KD. (2006). "A molecular link between the active component of marijuana and Alzheimer's disease pathology.". Mol Pharm 3 (6): 773–7. doi:10.1021/mp060066m. PMC 2562334. PMID 17140265. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2562334. 

Further reading

External links